Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges.
about
Analysis of the Resistance of Hepatitis C Virus NS5B Polymerase Inhibitors via Docking and Molecular Dynamics Simulation.Optimization of Benzoisothiazole dioxide inhibitory activity of the NS5B polymerase of HCV genotype 4 using ligand-steered homological modeling, reaction-driven scaffold-hopping and Enovo workflowNew pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors.Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development.Genotypic and phenotypic analyses of hepatitis C virus variants observed in clinical studies of VX-222, a nonnucleoside NS5B polymerase inhibitorLycorine-derived phenanthridine downregulators of host Hsc70 as potential hepatitis C virus inhibitors.
P2860
Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-nucleoside inhibitors of h ...... rogress and future challenges.
@en
Non-nucleoside inhibitors of h ...... rogress and future challenges.
@nl
type
label
Non-nucleoside inhibitors of h ...... rogress and future challenges.
@en
Non-nucleoside inhibitors of h ...... rogress and future challenges.
@nl
prefLabel
Non-nucleoside inhibitors of h ...... rogress and future challenges.
@en
Non-nucleoside inhibitors of h ...... rogress and future challenges.
@nl
P2860
P356
P1476
Non-nucleoside inhibitors of h ...... rogress and future challenges.
@en
P2093
Stephanie T Shi
P2860
P304
P356
10.4155/FMC.09.148
P577
2010-01-01T00:00:00Z